Intramuscular neridronate for the treatment of complex regional pain syndrome type 1: a randomized, double-blind, placebo-controlled study.
2021
Background:Complex regional pain syndrome type-1 (CRPS-1) is a severely disabling painful disease challenging to treat. This multicenter, randomized, double-blind placebo-controlled trial examined ...
Keywords:
-
Correction
-
Source
-
Cite
-
Save
35
References
1
Citations
NaN
KQI